Page last updated: 2024-11-03

rabeprazole and Hyponatremia

rabeprazole has been researched along with Hyponatremia in 1 studies

Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

Hyponatremia: Deficiency of sodium in the blood; salt depletion. (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"With the exception of lansoprazole, this study suggests an association between any newly initiated PPI-treatment and hospitalization due to hyponatremia."3.91Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study. ( Calissendorff, J; Falhammar, H; Lindh, JD; Mannheimer, B; Nathanson, D; Skov, J, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Falhammar, H1
Lindh, JD1
Calissendorff, J1
Skov, J1
Nathanson, D1
Mannheimer, B1

Other Studies

1 other study available for rabeprazole and Hyponatremia

ArticleYear
Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study.
    European journal of internal medicine, 2019, Volume: 59

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Esomeprazole; Female; Hospitalization; Humans; Hyponatre

2019